Navigation Links
OPKO Management and Israel's Minister of Science Open TASE Trading in Honor of OPKO'S Dual-Listing on TASE
Date:8/21/2013

TEL-AVIV, Israel, August 21, 2013 /PRNewswire/ --

This morning the Tel Aviv Stock Exchange (TASE) held an opening bell ceremony honoring the dual listing of the OPKO Health, Inc., which was attended by  Israel's Minister of Science, Technology and Space and senior management from OPKO, PROLOR Biotech and TASE.

     (Logo: http://photos.prnewswire.com/prnh/20130117/588933)

     (Photo: http://photos.prnewswire.com/prnh/20130821/635903 )

The Minister of Science, Technology and Space, Yaacov Peri, stated the OPKO's dual listing on TASE constitutes another stage in the process of establishing Israel as an international leader in the bio-pharma industries. The listing of multinational concern on the Tel Aviv Stock Exchange should not be taken for granted, particularly during these times of regional and economic turmoil. The dual listing underscores Israel's strength. "I hope that OPKO's listing is a harbinger for other international multinational companies."

Dr. Phillip Frost, OPKO's Chairman and CEO stated the "We at OPKO believe that we will profit from PROLOR's talent and experience. The merger between OPKO and PROLOR is a prime example of what cooperation between Israel and the U.S. and other countries can yield. PROLOR contains talented professionals, which to my mind constitute the heart and soul of Israel and the Israeli mind. What Israel needs today is 10 companies like Teva; one is not enough. I am certain that PROLOR, together with OPKO, will become a success story like Teva in the near future, and it is interesting to see that there are other companies here harboring the same potential. The Israeli mind does not cease to amaze and is definitely worth study and investment."

Ester Levanon, TASE CEO, said that "This is a special day for TASE. OPKO's dual listing is recognition of the special position the biomed sector holds at the Tel Aviv Stock Exchange, and it constitutes a vote of confidence in Israel's capital market. In the past years TASE has managed to turn into a hub for biomed companies. At the end of 2005 only 12 biomed firms were listed on TASE. Today 59 companies are listed, 7 of which are dual listed. This sector is larger than what is currently found on European exchanges."

In the picture (right to left): Shai Novik, CEO PROLOR; Dr. Phillip Frost, Chairman and CEO, OPKO; Ester Levanon, CEO, TASE; Yaacov Peri, Minister of Science, Technology and Space; Dr. Ron Malka, Interim Chairman of the Board, TASE.

Credit for photograph: Moshe Shay with compliments


    
    Orna Goren
    Deputy Manager
 
    Marketing & Communications Unit
    The Tel-Aviv Stock Exchange
    
    T: +972(3)5677405
    F: +972(3)5105376
    M: +972(52)3400843
    E: ornag@tase.co.il
    W: http://www.tase.co.il
    A: 54 Ahad Ha'am St., Tel-Aviv 65202, Israel



'/>"/>
SOURCE Tel Aviv Stock Exchange Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
2. Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference
3. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
4. Pain Management Therapeutics Market is Expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research
5. LIMS 24/7 and Ayrris: Big-Data Lab Management for Production-Scale NGS
6. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
7. Molecular Biomarkers for Cancer Detection and Management
8. Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
9. VG Life Sciences, Inc. Announces Management Changes
10. Elsevier Supports Russias ROSATOM Knowledge Management Program
11. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):